Elias Toubi completed his medical education and graduated from the 1st Medical Institute of Leningrad, Russia in 1975. He received his license in Internal Medicine at the Bnai Zion Medical Center in 1982. He subsequently gained his Allergy and Clinical Immunology license in Tel Aviv in 1986. In 1994 he spent a one-year fellowship (clinical research in systemic lupus erythematosus) at St Thomas' Hospital in London, UK. Later in 1998–9 he spent a second fellowship at the HSS (Hospital for Special Surgery) at Cornell, NY, USA. Professor Toubi has a number of research interests including autoimmunity and immune-regulatory mechanisms, i.e. B-regulatory cells. His current focus is on regulatory molecules such as semaphorin3A and CD72 and their role in autoimmune diseases. He is also a leader in the field of chronic spontaneous urticaria (CSU), namely diagnostic issues and treatment. One of his focuses is on the role of activated T-cells in CSU. He is active in organising International Schools for urticaria for young fellows under the supervision of GA2LEN. Professor Toubi is a member of the editorial board of many journals, including Autoimmunity Reviews, International Archives of Allergy & Immunology, Israel Medical Association Journal, Autoimmunity Highlights. He is also a member of international allergy associations such as the GA2LEN board.